LINC Linc AB
67.20SEK-0.59%Mkt Cap: 374.14M $P/E: 12.07Today
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place…
Industry Peers
Asset ManagementKey Statistics
Company
Market Cap374.14M USD
Enterprise Value357.88M USD
Revenue (TTM)30.12M USD
Gross Profit-152.18K USD
Net Income (TTM)-38.23M USD
Revenue/Share5.44 SEK
Last Price67.20 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountrySE
SectorFinancial Services
IndustryAsset Management
ISINSE0015949433
Valuation
P/E (Trailing)12.07
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue11.88
P/S12.37
P/B0.87
EPS (TTM)5.60
EPS (Forward)—
52W Range
58.9043% of range78.10
52W High78.10 SEK
52W Low58.90 SEK
Profitability
Gross Margin-31.82%
Oper. Margin98.63%
EBITDA Margin0.00%
Profit Margin-7992.94%
ROE-9.02%
ROA-9.00%
Growth
Revenue Growth-33.50%
Earnings Growth-26.40%
Cash Flow & Leverage
Operating CF-25.41M USD
CapEx (TTM)—
FCF Margin71.35%
FCF Yield5.74%
Net Debt-16.26M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio27.68
Quick Ratio25.11
Book Value/Sh77.92 SEK
Cash/Share2.94 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)72.00 SEK
Upside (mean)+7.1%
Target Range72.00 SEK – 72.00 SEK
# Analysts1
Ownership
Shares Out.57.60M
Float22.20M
Insiders60.77%
Institutions25.56%
Technical
SMA 5072.58 (-7.4%)
SMA 20070.52 (-4.7%)
Beta0.70
S&P 52W Chg14.58%
Avg Vol (30d)33.47K
Avg Vol (10d)39.38K
Technical Indicators
RSI (14)27.8
MACD-1.3138
MACD Signal-1.0821
MACD Hist.-0.2317
BB Upper73.50 SEK
BB Middle70.35 SEK
BB Lower67.20 SEK
BB Width8.96%
ATR (14)1.127 SEK
Vol Ratio (20d)1.20x